Trial site
American Research Corporation
- 4running trials
- 8closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Primary biliary cholangitis5 trials
- Liver cirrhosis3 trials
- Fatty liver disease (MASLD/MASH)2 trials
- High blood pressure1 trial
- Hypothyroidism1 trial
- Obesity1 trial
- Type 2 diabetes1 trial
- Wilson disease1 trial
- Phase
- Phase 35 trials
- Phase 24 trials
- Phase 12 trials
- Status
- Completed6 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Gilead Sciences2 trials
- Ipsen2 trials
- Alentis Therapeutics AG1 trial
- Amgen1 trial
- Boehringer Ingelheim1 trial
- and 5 more
Running trials
Recruiting
Active, not recruiting
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Active, not recruiting
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity1 recruiting
- Primary biliary cholangitis1 recruiting
Closed trials
Completed
Terminated
Completed
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Completed
Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism
Completed
A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026